More articles about Bristol Myers | Wall St. Cheat Sheet

October 07, 2012

What’s Next for Pfizer?

While the drug portfolio of pharmaceutical manufacturer Pfizer remains unmatched, U.S. patent protection for two of its biggest drugs, Lipitor and Protonix, ended in 2011, leaving analysts to speculate whether Pfizer has a pipeline large enough to replace its largest earners...

July 20, 2012

HP DECLARES Dividend and 4 Hot Morning Stocks Rounding Out the Week

Headlines you need to know this morning…

July 02, 2012

VMware’s LOWER PRICE TARGET and 4 Analyst Comments Traders are Chatting About Now

Here's what analysts had to say about these companies today...

June 26, 2012

Healthcare Biz Recap: Amylin in FDA HOT WATER, Rosetta Genomics OFFERS Up Shares

Your Cheat Sheet to the top healthcare business news ...

June 26, 2012

Hershey’s Long-Term Sales Look SWEET and 3 Analyst Alerts in Our Sights

Here's what analysts had to say about these companies today...

June 20, 2012

Healthcare Biz Recap: Forest Laboratories Icahn ATTACK, Supreme Court JITTERS

Your Cheat Sheet to the top healthcare business news ...

June 06, 2012

Healthcare Biz Recap: Merck’s NEW Drug Application, Abbott Labs LOSES

Your Cheat Sheet to the top healthcare business news ...

June 04, 2012

Healthcare Biz Recap: Dendreon BOMBS, Cancer Cures Galore

Your Cheat Sheet to the top healthcare business news ...

June 04, 2012

3 BOMBS Getting Dropped on Dendreon Now

Dendreon (NASDAQ:DNDN) is one of the most popular day trading stocks on the market. Here are 3 new data points giving short sellers ammunition for huge gains: 1) Following the trials of cancer drugs from Johnson & Johnson (NYSE:JNJ) and Medivation (NASDAQ:MDVN) that yielded positive results so far as Roth Capital is concerned, the company [...]